Epiconcept
Epiconcept is a Paris-based SaaS publisher founded in 1996 that builds public health information systems, screening/vaccination management suites, and epidemiological surveillance tools for government health agencies, hospitals, and international NGOs.
- Company typePrivate
- Founded1996
- HeadquartersParis, France
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Epiconcept does
Epiconcept is a French privately-held SaaS software publisher founded in 1996 and headquartered in Paris, specializing in public health information systems, epidemiological surveillance, and biostatistics services. The company serves public health institutions, government health agencies, hospitals, research organizations, and international NGOs across approximately 50 countries, with named customers including WHO, ECDC, Santé Publique France, AP-HP, INSERM, and Médecins Sans Frontières. Its product portfolio is anchored on the proprietary Voozanoo/Epicraft technical framework and organized around the Suite Santé Prévention (SSP) integrated suite — covering vaccination (Vaxi), STI/HIV screening (Cupidon), tuberculosis (Damoc), cancer screening (e-SIS 3D), and neonatal screening (Neonat) — alongside a parallel Epiconcept ONG line (Homère, Saga, Saga Stock) serving humanitarian organizations.
The company operates a sales-led, enterprise field motion targeting institutional buyers, distributing through public procurement frameworks UGAP (2023–2027), Resah (2020–2028), and UniHA LOGMED (2024–2028), as well as direct sales to supranational bodies. Revenue is generated through SaaS subscriptions, custom development projects using Voozanoo/Epicraft, and applied epidemiology/biostatistics professional services. All hosting runs on ISO 27001/HDS-certified infrastructure (certified since 2019; HDS accreditation since 2012), a regulatory prerequisite for handling French personal health data. The company reached 100+ employees in 2023, opened capital to Groupe Softway Medical in 2024, and became a Société à Mission in May 2025 with public health purpose statements embedded in its bylaws.
Epiconcept firmographics
Firmographics- Name
- Epiconcept
- Legal name
- Epiconcept SAS
- Website
- https://epiconcept.fr
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Epiconcept is a Paris-based SaaS publisher founded in 1996 that builds public health information systems, screening/vaccination management suites, and epidemiological surveillance tools for government health agencies, hospitals, and international NGOs.
- Ownership category
- akta.pro rank
Epiconcept industry classification
Industry- Product category
- Public Health Software
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- API Management & Developer Portals for Health Data (HLACABAD), Electronic Data Capture (EDC) Platforms (HLACAOAA), Health Systems Strengthening & Global Health Technical Assistance (BPADAEAH)
Keywords
Where Epiconcept is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Epiconcept business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- SaaS Software Subscriptions: Recurring subscription revenue from proprietary SaaS health software solutions including Suite Santé Prévention, Vaxi, Cupidon, Damoc, Neonat, E-SIS, Homère, Saga, and Saga Stock. Delivered via web with cloud hosting and maintenance included.
- Custom Development Projects: Custom health information system development using Voozanoo/Epicraft framework. Includes co-construction methodology, agile project management, and ongoing support. Services include system design, implementation, and maintenance for specific institutional requirements.
- Epidemiology Services: Applied research coordination, epidemiological surveillance support, biostatistics services, and training. Services include protocol development, data analysis, and capacity building for public health organizations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | SaaS licensing via UGAP multi-éditeurs market |
| Subscription | Multi-year contract | Resah multi-éditeurs market |
| Subscription | Multi-year contract | UniHA LOGMED market |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Epiconcept product offering
Product offeringCore offering
Epiconcept develops and operates SaaS e-health software for public health actors, including the Suite Santé Prévention (SSP) and its modules for vaccination and screening management (Cupidon, Vaxi, Damoc, e-SIS 3D, Neonat), NGO solutions (Homère, Saga, Saga Stock), and a Health Data Warehouse (EDS). All solutions are built on the proprietary Voozanoo/Epicraft platform and delivered via 100% web-based SaaS with ISO 27001/HDS-certified hosting, complemented by custom development, epidemiology, and biostatistics services.
Product overview
Epiconcept offers a comprehensive e-health SaaS product portfolio centered on prevention, screening, and public health management. The Suite Santé Prévention (SSP) serves as the core integrated platform managing cross-cutting screening and vaccination programs, with specialized modules including Cupidon (IST/VIH screening), Vaxi (vaccination), Damoc (tuberculosis), e-SIS 3D (cancer screening), and Neonat (neonatal screening). The company also provides the Voozanoo/Epicraft technical framework for custom health information systems, Health Data Warehouse (EDS) services, and a dedicated NGO solutions brand (Epiconcept ONG) with Homère, Saga, and Saga Stock for humanitarian organizations. Epiconcept operates 100% web-based software solutions serving 50,000+ health professionals across 12+ million beneficiaries.
Differentiator
Problem solved
Functional benefit
Brands
- Suite Santé Prévention: Comprehensive prevention and screening management suite for health programs including vaccination, IST/Hepatitis/HIV screening, cancer screening, neonatal screening, and tuberculosis.
- Vaxi
- Cupidon
- Damoc
- e-SIS 3D
- Neonat
- Wepi
- Epifiles
- Voozanoo
- Epistudy
- Homère
- Saga
- Saga Stock
Products and services
- Suite Santé Prévention (SSP)
Quantifiable outcome
- Nearly 100% of neonates born in France screened through NéoNat solution
- +5 more outcomes
Companies that use Epiconcept
Customer profileNamed customers13 records
Segments5 records
Ideal customer profiles5 records
Epiconcept technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature16 records
Epiconcept partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Groupe Softway MedicalcoreIn 2024, Epiconcept opened capital to Groupe Softway Medical, an actor complementary in the health sector sharing the same vision. This strategic partnership enables complementarity in e-health, data science, and epidemiology at the service of population health. The four original associates (Loïc Flachet, Guillaume Jeannerod, Valérie Nancey, Etienne Sévin) continue to lead the company under this new shareholder structure.
- Healthcare Data InstituteminorEpiconcept is a member of the Healthcare Data Institute, an organization focused on health data innovation and best practices.
- MedicenminorEpiconcept is a member of Medicen, the French competitiveness cluster for digital health, supporting innovation in health technologies.
- UGAP (Union des Groupements d'Achats Publics)coreUGAP multi-éditeurs market agreement (April 2023 - April 2027) enables public buyers to acquire Epiconcept software solutions through the UGAP catalog, including licenses, maintenance, and support services. The agreement covers standard software and specific professional services.
- Resah (Réseau des Acheteurs Hospitaliers)coreResah multi-éditeurs market (2020-2028) and Apollo market (2024-2028) provide framework agreements through which health sector buyers can procure Epiconcept solutions. Resah serves over 1700 establishments in French healthcare sector.
- UniHA (L'Achat Coopératif des Hôpitaux Publics)coreUniHA LOGMED market (September 2024 - June 2028) for medical software enables public hospitals to acquire Epiconcept solutions through the cooperative purchasing organization.
- European Centre for Disease Prevention and Control (ECDC)coreEpiconcept provides ongoing technical support to ECDC for surveillance projects including VEBIS vaccine effectiveness studies, SARI surveillance, EPHESUS evaluation, Legionnaires' disease surveillance, ArboRisk, and R training programs. The partnership involves development of R packages, protocols, and multi-country analyses.
- World Health Organization (WHO)coreEpiconcept supports WHO in European Region, African Region, and Eastern Mediterranean Region for COVID-19 and influenza vaccine effectiveness networks. Activities include developing generic protocols, technical support to countries, pooling data, and capacity building through workshops and training.
- European CommissioncoreEpiconcept participates in Horizon 2020 research projects including PANDEM (pandemic preparedness), SpIDnet, and I-MOVE+. Coordinates European surveillance networks and vaccine effectiveness studies funded by European Commission.
- France CohortesminorEpiconcept supports population cohort management for French longitudinal studies including ELFE, SEPAGES, AGRICAN, and COSET registries.
Scale indicators11 records
Recent moves12 records
Expansion highlights6 records
Epiconcept competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva is the leading life sciences cloud platform covering EDC (Veeva EDC), CTMS, ePRO and clinical data. As a broad incumbent in clinical and life sciences informatics, it represents the upper-end benchmark for what a scaled version of Epiconcept's e-clinical stack could look like.
- Dedalus Group: Dedalus is the parent of Maincare and one of the largest European healthcare IT groups, with deep presence in hospital, diagnostic and public health information systems. It is the most relevant group-level incumbent competing head-to-head with Epiconcept in French and EU public health tenders.
- CompuGroup Medical: CompuGroup Medical is a major European healthcare IT vendor providing EHR, hospital information systems and physician practice software across multiple European countries — overlapping with Epiconcept's public health/regional health agency footprint in France and beyond.
- Medidata Solutions (Dassault Systèmes): Medidata, owned by Dassault Systèmes, is the dominant EDC/CTMS/RTSM platform for clinical trials globally. While broader and more pharma-focused than Epiconcept, it overlaps with Epiconcept's Voozanoo-based EDC and clinical study tooling.
Direct peers
- Enovacom (Orange Business): Enovacom, the healthcare data interoperability arm of Orange Business, provides HIE, health data hosting and integration solutions for French hospitals and public health agencies. It competes with Epiconcept in the EDS/health data warehouse and HDS-certified interoperability space.
- Castor (EDC): Castor is a cloud-based EDC platform used for clinical and observational studies, registries and real-world data capture — closely comparable to Epiconcept's Epistudy, Wepi and Voozanoo-based study management offerings for epidemiological research.
- OpenHealth: OpenHealth is a French health-data observability and epidemiology firm providing real-world evidence, public health indicators and disease surveillance analytics — overlapping with Epiconcept's data science, surveillance and EDS offerings for French public health actors.
- Maincare (Dedalus): Maincare, a Dedalus Group subsidiary, is one of the largest French e-health IT vendors serving hospitals, regional health agencies and public health programs with EHR, patient records and screening platforms. It is the most direct French competitor to Epiconcept's public health information systems and SSP suite.
Others
- Groupe Softway Medical: Groupe Softway Medical is Epiconcept's parent company following the 2024 capital opening; it is a French e-health group focused on hospital information systems. Listed as an ecosystem/parent peer given it provides shared distribution (SantExpo, group sales channel) and a comparable French e-health software franchise.
Emerging players
- Doctolib (REEPORT): Doctolib acquired REEPORT, a French cancer screening management solution that competes with Epiconcept's e-SIS 3D. As Doctolib pushes deeper into coordination of organized screening programs, REEPORT is an emerging adjacent/competing offering to Epiconcept's SSP module.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Epiconcept social profiles
Digital presenceEpiconcept compliance and trust
Trust signalCompliance6 records
Epiconcept financial estimates
Financial estimateRevenue estimate
Valuation estimate
Epiconcept leadership team
Management profileNumber of profiles
Profiles17 records
Epiconcept subsidiaries and ownership
Company hierarchySubsidiaries2 records
Epiconcept funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Epiconcept M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Epiconcept
What does Epiconcept do?
Epiconcept develops and operates SaaS e-health software for public health actors, including the Suite Santé Prévention (SSP) and its modules for vaccination and screening management (Cupidon, Vaxi, Damoc, e-SIS 3D, Neonat), NGO solutions (Homère, Saga, Saga Stock), and a Health Data Warehouse (EDS). All solutions are built on the proprietary Voozanoo/Epicraft platform and delivered via 100% web-based SaaS with ISO 27001/HDS-certified hosting, complemented by custom development, epidemiology, and biostatistics services.
Is Epiconcept a public or private company?
Epiconcept is a private company. It is classified as corporate owned and is currently operating.
When was Epiconcept founded?
Epiconcept was founded in 1996. It employs 51 to 100 people.
Where is Epiconcept based?
Epiconcept is headquartered in Paris, France, in the Europe region.
How does Epiconcept make money?
Three revenue lines are on record. SaaS Software Subscriptions are the primary driver. The others are custom Development Projects and epidemiology Services.
Who are Epiconcept's main competitors?
Broad incumbents on record are Veeva Systems, Dedalus Group, CompuGroup Medical and Medidata Solutions (Dassault Systèmes). Direct peers are Enovacom (Orange Business), Castor (EDC), OpenHealth and Maincare (Dedalus). Groupe Softway Medical is listed as an others. Doctolib (REEPORT) is listed as an emerging player.
Does Epiconcept have an API?
No public API is recorded for Epiconcept.
What industry is Epiconcept in?
Epiconcept's product category is Public Health Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACABAD, API Management & Developer Portals for Health Data. Its NAICS code is 513210 and its SIC code is 7372.